PT Suparma Tbk

As of June 30, 2026, PT Suparma Tbk carries a market capitalization of 844.67B, placing it among publicly traded companies globally. Its enterprise value stands at 1.63T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, PT Suparma Tbk has 5.33B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, PT Suparma Tbk maintains a current ratio of 1.96, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, PT Suparma Tbk recorded 21.66B in income tax expense.

As of the close on October 23, 2026, PT Suparma Tbk's stock has declined approximately 30.46% over the past 52 weeks. The 50-day moving average sits at 164.20, while the 200-day moving average is 167.54.

As of June 30, 2026, PT Suparma Tbk holds 127.08B in cash and equivalents against 907.54B in total debt, resulting in a net debt position of 676.49B. Total book value stands at 2.53T, with working capital of 768.04B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

PT Suparma Tbk's most recent stock split took place on July 9, 2026 with a 10:13 split ratio.